Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 ...

Scientists at The Jackson Laboratory (JAX) have developed mouse models that survive premature death and enable pre-clinical ...

Building blocks for flexible bioprocessing must also be easy to install and take little time to train operators.

The Synthetic Human Genome, or Syn HG, a project launched on June 26th, aims to change that. Funded partly by Wellcome, a ...

A New Haven-based biotech company has developed advanced technology that uses gene-editing to improve the quality of lettuce.

A newer technology called genome editing or gene editing has emerged in the last decade. “Gene editing is basically just conventional breeding, but done more intelligently,” she summarizes. “This ...

Repositioning genes awakens fetal hemoglobin to treat disease. CRISPR editing may change future gene therapy. Researchers ...

Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...

Eli Lilly offered a 115% premium for Verve, signaling a major vote of confidence in gene editing platforms. HC Wainwright and William Blair downgraded Verve after the deal. Market-moving news hits ...

Gene-editing companies hold potential to treat and cure diseases caused by genetic variants. As the name suggests, they make changes or correct defects in the organism's DNA.

WHAT STUDENTS CAN DO Watch this video to learn more about what exactly CRISPR gene editing is and its potential impact on reducing the transmission of other diseases, such as Lyme Disease.

A gene-editing delivery system developed by UT Southwestern Medical Center researchers simultaneously targeted the liver and lungs of a preclinical model of a rare genetic disease known as alpha-1 ...